characteristics.text: SAMN40078653
characteristics.characteristic: External Id
characteristics.text: Obsidian Therapeutics
characteristics.characteristic: INSDC center name
characteristics.text: 2025-05-20T00:00:00Z
characteristics.characteristic: INSDC first public
characteristics.text: 2025-05-20T16:13:02.191Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS20546457
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Human
characteristics.characteristic: NCBI submission model
characteristics.text: Human.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS20546457
characteristics.characteristic: SRA accession
characteristics.text: Day 21
characteristics.characteristic: age
characteristics.text: Obsidian Therapeutics
characteristics.characteristic: biomaterial_provider
characteristics.text: 2023-10
characteristics.characteristic: collection_date
characteristics.text: Day 21 - UT 3000 IU/mL IL-2
characteristics.characteristic: description
characteristics.text: USA
characteristics.characteristic: geo_loc_name
characteristics.text: ex vivo cultured T cells
characteristics.characteristic: isolate
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: N/A
characteristics.characteristic: sex
characteristics.text: Tumor infiltrating T cells
characteristics.characteristic: tissue
characteristics.text: Day 21 - UT 3000 IU/mL IL-2
characteristics.characteristic: title
characteristics.text: Day 21 - UT 3000 IU/mL IL-2
characteristics.characteristic: treatment